Back
Evonetix Evaleo Gene Synthesis Platform
webevonetix.com·evonetix.com/gene-synthesis
Relevant to AI safety and biosecurity communities tracking dual-use biotechnology; advances in gene synthesis are a key risk factor in biological catastrophe scenarios, and this platform represents the state of the art in the field.
Metadata
Importance: 35/100tool pagehomepage
Summary
Evonetix's Evaleo is a silicon chip-based DNA synthesis platform designed for high-fidelity, scalable gene synthesis. The technology aims to improve accuracy and throughput in synthetic biology applications. As a dual-use technology, it has implications for both beneficial biotech research and biosecurity risks.
Key Points
- •Evaleo uses silicon chip technology to enable parallel, high-accuracy DNA synthesis at scale
- •The platform targets improved fidelity over traditional column-based synthesis methods, reducing error rates in long sequences
- •Dual-use concern: advances in gene synthesis capability could lower barriers to engineering dangerous pathogens
- •Relevant to biosecurity policy debates around screening and oversight of DNA synthesis orders
- •Part of broader landscape of emerging biotechnologies that intersect with existential and catastrophic risk
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Bioweapons Risk | Risk | 91.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20263 KB
Gene synthesis technology to scale engineering biology
Sep
OCT
Nov
10
2024
2025
2026
success
fail
About this capture
COLLECTED BY
Collection: Common Crawl
Web crawl data from Common Crawl.
TIMESTAMPS
The Wayback Machine - https://web.archive.org/web/20251010220746/https://www.evonetix.com/gene-synthesis
evonetix
-->
Gene synthesis
Technology
Applications
Search
Search
Company
About
People
Investors
Careers
Latest
Contact
Search
There’s more potential diversity within DNA than there are planets in the universe.
Biology has shaped the world around us, but we’ve barely begun to explore the possibilities contained within its vast diversity.
Imagine what society could achieve if we harnessed this potential.
Biology is on the cusp of a revolution that will transform society and solve some of humanity’s biggest problems. But to make it a reality, we’ll need to build genes and proteins at a scale not currently achievable.
The world needs better ways to make DNA longer, faster and more accurately than we can today. That will expand the accessible design space to everyone in synthetic biology.
Raquel Sanches-Kuiper
Vice President of Science & Applications
Read Raquel's Interview
Gene synthesis is key to scaling engineering biology
Engineering biology is growing rapidly, but demand for gene synthesis is not being met by current technologies. This gap will only widen further with advancements in AI functional protein design and automation.
Only a highly disruptive technology is likely to achieve the significant improvements needed to unlock the opportunities of engineering biology. By developing a benchtop instrument capable of highly parallel DNA synthesis and assembly with error removal, Evonetix is putting rapid and accurate gene synthesis directly in the hands of researchers.
Whitepaper
Optimizing the Design-Build-Test-Learn (DBTL) cycle to scale engineering biology
A deep dive into the opportunities afforded by engineering biology alongside challenges in realizing its potential, including advantages and limitations of common DNA synthesis workflows and recent developments that aim to accelerate this process.
Read the whitepaper
The world's first rapid, benchtop synthesis platform
Unleashing the future of healthcare
A vision
... (truncated, 3 KB total)Resource ID:
f412700e54865ebf | Stable ID: ZDMzMDNiMz